# Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (Text with EEA relevance), Division 1: Serological tests

Extent: E+W+S+N.I.

(a) tests for blood samples
(i) buffered Brucella antigen tests;
(ii) complement fixation test (CFT)
(iii) indirect enzyme-linked immunosorbent assay (I-ELISA)
(iv) fluorescence polarisation assay (FPA)
(v) competitive enzyme-linked immunosorbent assay (C-ELISA)
(b) tests for milk samples
(i) ring test (MRT)
(ii) I-ELISA

---
Source: https://www.legislation.gov.uk/eur/2020/689/annex/III/section/1/division/1 (the official version)
Page: https://openlegislation.uk/eu-regulation-2020-689/annex-III/section-1/division-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.